A -trace variant protein is the major constituent of the amyloid fibrils in patients from Iceland with hereditary cerebral hemorrhage with amyloidosis. The protein consists of 110 residues and is similar to human urinary V-trace basic protein (or cystatin C) beginning at its 11th aminoterminal residue. It has an amino acid substitution (glutamine for leucine) at position 58 (position 68 in v-trace numbering), which is near the proposed active site of related proteinsnamely, cysteine protease inhibitors and kininogens. It is postulated that a point mutation has occurred, leading to the production of an unusual protein that is abnormally degraded, bound, and/or precipitated. Alternatively, Vtrace basic protein may be genetically polymorphic, and the variant described here may represent an as-yet-undiscovered isotype or an allelic form that is linked to, but not responsible for, the deposition disease. Our data on the structure of a V-trace variant protein suggests that its gene expresses a polyprotein precursor in which active peptides are flanked by basic amino acid residues that permit cleavage to liberate small internal peptides. It is likely that the nucleotide sequence coding for Arg-Xaa and Lys-Xaa repeated several times in the molecule may function as alternative splicing sites for mRNA processing.Amyloidosis comprises a heterogeneous group of disorders of different etiology characterized by the relentless deposition (mainly extracellular) of a number of fibrillar proteins, which may be distinguished from each other immunohistologically and biochemically. Amyloid fibrils are composed of low molecular weight subunits that originate by polymerization and/or proteolysis of serum proteins. These subunit proteins have a predominant 3-pleated-sheet configuration, as shown by spectroscopic studies and x-ray diffraction (1).Hereditary cerebral hemorrhage with amyloidosis (HCH-WA) is an autosomal dominant form of amyloidosis that is restricted to the cerebral vasculature and leads to hemorrhagic and thrombotic strokes causing death before the age of 40 yr; 128 affected family members within eight families originating from one geographical area in Iceland have been identified (refs. 2 and 3; unpublished studies). Recently a similar autosomal dominant cerebral amyloid angiopathy has been described in The Netherlands (4). The histopathology of HCHWA brains is similar to that of the congophilic angiopathy associated with some cases of Alzheimer disease and cases of cerebral hemorrhage caused by sporadic congophilic angiopathy. In HCHWA there are no plaques or neurofibrillary tangles, and the amount of vascular amyloid is quantitatively much greater than in the two other forms of cerebral amyloid angiopathy (5, 6), making chemical extraction of the amyloid fibrils feasible. We have reported (7) the amino-terminal sequence of the amyloid fibrils obtained from the brain of patients dying of HCHWA. This paper presents the complete primary sequence and discusses its relationship to related proteins and its potential ...